Oxibato De Sodio Zentiva (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Oxibato De Sodio Zentiva, is a central nervous system depressant presented as a solution for oral use. It is indicated for the treatment of cataplexy and excessive daytime sleepiness in adults with narcolepsy. GNH USA supplies Oxibato De Sodio Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxibato De Sodio Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxibato De Sodio Zentiva is a sodium oxybate formulation that acts on the central nervous system to improve sleep‑related symptoms.

- Narcolepsy with cataplexy: reduces the frequency of cataplexy episodes and improves nighttime sleep quality. - Narcolepsy with excessive daytime sleepiness: decreases daytime sleepiness and improves overall alertness. - Secondary sleep disorders associated with narcolepsy: helps consolidate nocturnal sleep, leading to better daytime functioning.

Sodium oxybate may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Drowsiness: feeling   - Nausea: upset  - Headache  - Dizziness - Vomiting - Nasal congestion

Serious or Rare Side Effects: - Respiratory depression: reduced  - Seizure  - Severe hypotension  - Allergic reactions  - Confusion  - Abnormal heart rhythm 

When using Sodium   g    t   t   ewline   ewline  ewline  \n ":["